Santiago Rojas1, José Raul Herance2, Sergio Abad2, Xavier Jiménez2, Deborah Pareto2,3, Alba Ruiz2, Èlia Torrent2, Francisca P Figueiras2, Foteini Popota2, Francisco J Fernández-Soriano2, Anna M Planas4, Juan D Gispert2,3. 1. Institut d'Alta Tecnologia, Parc de Recerca Biomèdica de Barcelona (IAT-PRBB) CRC Corporació Sanitària, C/Dr Aiguader 88, 08003, Barcelona, Spain. srojas@crccorp.es. 2. Institut d'Alta Tecnologia, Parc de Recerca Biomèdica de Barcelona (IAT-PRBB) CRC Corporació Sanitària, C/Dr Aiguader 88, 08003, Barcelona, Spain. 3. CIBER en Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Zaragoza, Spain. 4. Department of Brain Ischemia and Neurodegeneration, Institut d'Investigacions Biomèdiques de Barcelona (IIBB)-Consejo Superior de Investigaciones Científicas (CSIC), Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Abstract
PURPOSE: [¹⁸F]Fluoromisonidazole (¹⁸F-FMISO) is a nitroimidazole derivative that has been proposed as a positron emission tomography (PET) radiotracer to detect hypoxic tissue in vivo. This compound accumulates in hypoxic but viable tissue and may be a good candidate for evaluating the ischemic penumbra. We evaluated the time course of ¹⁸F-FMISO uptake using PET in a rat model of permanent cerebral ischemia and the correlation with histological changes. PROCEDURES: Rats (n = 14) were subjected to permanent ischemia by intraluminal occlusion of the middle cerebral artery in order to assess by PET the uptake of ¹⁸F-FMISO at various times over 24 h following ischemia. The PET results were compared to histological changes with Nissl and 2,3,5 triphenyltetrazolium chloride staining. RESULTS: Elevated uptake of ¹⁸F-FMISO was detected in the infarcted area up to 8 h after occlusion but was no longer detected at 24 h, a time point coincident with pan necrosis of the tissue. CONCLUSIONS: Our findings suggest that salvageable tissue persists for up to 8 h in this rat model of brain ischemia. We propose ¹⁸F-FMISO PET as a tool for evaluating the ischemic penumbra after cerebral ischemia.
PURPOSE: [¹⁸F]Fluoromisonidazole (¹⁸F-FMISO) is a nitroimidazole derivative that has been proposed as a positron emission tomography (PET) radiotracer to detect hypoxic tissue in vivo. This compound accumulates in hypoxic but viable tissue and may be a good candidate for evaluating the ischemic penumbra. We evaluated the time course of ¹⁸F-FMISO uptake using PET in a rat model of permanent cerebral ischemia and the correlation with histological changes. PROCEDURES: Rats (n = 14) were subjected to permanent ischemia by intraluminal occlusion of the middle cerebral artery in order to assess by PET the uptake of ¹⁸F-FMISO at various times over 24 h following ischemia. The PET results were compared to histological changes with Nissl and 2,3,5 triphenyltetrazolium chloride staining. RESULTS: Elevated uptake of ¹⁸F-FMISO was detected in the infarcted area up to 8 h after occlusion but was no longer detected at 24 h, a time point coincident with pan necrosis of the tissue. CONCLUSIONS: Our findings suggest that salvageable tissue persists for up to 8 h in this rat model of brain ischemia. We propose ¹⁸F-FMISO PET as a tool for evaluating the ischemic penumbra after cerebral ischemia.
Authors: S J Read; T Hirano; D F Abbott; R Markus; J I Sachinidis; H J Tochon-Danguy; J G Chan; G F Egan; A M Scott; C F Bladin; W J McKay; G A Donnan Journal: Ann Neurol Date: 2000-08 Impact factor: 10.422
Authors: Daniel J Rubins; William P Melega; Goran Lacan; Baldwin Way; Alain Plenevaux; Andre Luxen; Simon R Cherry Journal: Neuroimage Date: 2003-12 Impact factor: 6.556
Authors: Kaisa Lehtiö; Vesa Oikonen; Samuel Nyman; Tove Grönroos; Anne Roivainen; Olli Eskola; Heikki Minn Journal: Eur J Nucl Med Mol Imaging Date: 2002-10-30 Impact factor: 9.236
Authors: C J Mathias; M J Welch; M R Kilbourn; P A Jerabek; T B Patrick; M E Raichle; K A Krohn; J S Rasey; D W Shaw Journal: Life Sci Date: 1987-07-13 Impact factor: 5.037
Authors: Gaber Komar; Marko Seppänen; Olli Eskola; Paula Lindholm; Tove J Grönroos; Sarita Forsback; Hannu Sipilä; Sydney M Evans; Olof Solin; Heikki Minn Journal: J Nucl Med Date: 2008-11-07 Impact factor: 10.057
Authors: S J Read; T Hirano; D F Abbott; J I Sachinidis; H J Tochon-Danguy; J G Chan; G F Egan; A M Scott; C F Bladin; W J McKay; G A Donnan Journal: Neurology Date: 1998-12 Impact factor: 9.910
Authors: Masashi Takasawa; John S Beech; Tim D Fryer; Young T Hong; Jessica L Hughes; Keiji Igase; P Simon Jones; Rob Smith; Franklin I Aigbirhio; David K Menon; John C Clark; Jean-Claude Baron Journal: J Cereb Blood Flow Metab Date: 2006-10-11 Impact factor: 6.200
Authors: Josef A Alawneh; Ramez R Moustafa; S Tulasi Marrapu; Ulf Jensen-Kondering; Rhiannon S Morris; P Simon Jones; Franklin I Aigbirhio; Tim D Fryer; T Adrian Carpenter; Elizabeth A Warburton; Jean-Claude Baron Journal: Eur J Nucl Med Mol Imaging Date: 2013-10-15 Impact factor: 9.236
Authors: Tim D Fryer; Sohail Ejaz; Ulf Jensen-Kondering; David J Williamson; Sergey Sitnikov; Stephen J Sawiak; Franklin I Aigbirhio; Young T Hong; Jean-Claude Baron Journal: PLoS One Date: 2017-11-01 Impact factor: 3.240